Welcome to our dedicated page for SolarWindow Technologies SEC filings (Ticker: WNDW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on SolarWindow Technologies's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into SolarWindow Technologies's regulatory disclosures and financial reporting.
SolarWindow Technologies, Inc. filed an S-1 registration statement describing an offering to permit resale of shares by selling stockholders and outlining the company’s business, risks, use of proceeds, and governance. The filing references the Annual Report for fiscal years ended August 31, 2024 and August 31, 2023, and a Quarterly Report for the periods ended May 31, 2025 and May 31, 2024. The company describes its LiquidElectricity® Coatings technology intended to generate electricity on glass and flexible substrates, notes ongoing work with NREL on coating and roll-to-roll manufacturing, and lists intended uses of proceeds including commercialization, manufacturing automation, capital expenditures, R&D, IP protection, and hiring. The prospectus highlights material risks: technology may not be commercially viable or scalable, competitors could develop superior solutions, patents may not issue or be enforceable, integration risks from acquisitions, and typical market and liquidity factors affecting share price. Management and certain option grants are disclosed, and the offering duration is defined with resale and Rule 144 contingencies.